Potential Pathogenic Inflammatory Mechanisms of Endothelial Dysfunction Induced by Type 2 Diabetes Mellitus

E-ISSN： 1873-4286|17|37|4147-4158

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.37, 2011-12, pp. : 4147-4158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanisms, Significance and Treatment of Vascular Dysfunction in Type 2 Diabetes Mellitus: Focus on Lipid-Regulating Therapy

By Woodman Richard J. Chew Gerard T. Watts Gerald F.

Drugs, Vol. 65, Iss. 1, 2005-01 ,pp. : 31-74

Adis International

Access to resources Recommend Favorite

Future anti-inflammatory metabolic and cardiovascular management of Type 2 diabetes mellitus

By Laight David W

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 11, 2003-11 ,pp. : 1683-1689

Informa Healthcare

Access to resources Recommend Favorite

Thiazolidinediones Anti-Inflammatory and Anti-Atherosclerotic Effects in Type 2 Diabetes Mellitus

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 3, 2008-09 ,pp. : 217-223

Bentham Science Publishers

Access to resources Recommend Favorite

Hyperglycemia and hyperlipidemia are associated with endothelial dysfunction during the development of type 2 diabetes

By Okon Elena B. Chung Ada W.Y. Zhang Hongbin Laher Ismail van Breemen Cornelis

Canadian Journal of Physiology and Pharmacology, Vol. 85, Iss. 5, 2007-05 ,pp. : 562-567

NRC Research Press

Access to resources Recommend Favorite

Biological Mechanisms Linking Alzheimer’s Disease and Type-2 Diabetes Mellitus

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 7, 2014-09 ,pp. : 1192-1201

Bentham Science Publishers

Access to resources Recommend Favorite